Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2023-07-17 00:00:00 ET · period of report 2023-07-13 · accession 0001209191-23-042495 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-07-17 | 2023-07-13+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.05 | -2,400 | 528.0K | -0.5% | -$38.5K |
| DM | 2023-07-17 | 2023-07-13+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +2,400 | 529.9K | +0.5% | +$1,464 |
| DM | 2023-07-17 | 2023-07-13+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.00 | -2,400 | 137.6K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-17 | S | D | 1,900 | $16.03 | 527,981 | D | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.10. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 2 | Common | Common Stock | 2023-07-13 | S | D | 500 | $16.13 | 527,981 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.05 and $16.25. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 3 | Common | Common Stock | 2023-07-13 | M | A | 500 | $0.61 | 528,481 | D | — | — | |
| 4 | Common | Common Stock | 2023-07-17 | M | A | 1,900 | $0.61 | 529,881 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-07-13 | M | D | 500 | $0.00 | 139,510 | D | $0.61 · — to 2030-01-26 | 500 Common Stock | (F4) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-07-17 | M | D | 1,900 | $0.00 | 137,610 | D | $0.61 · — to 2030-01-26 | 1,900 Common Stock | (F4) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |